Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)
Company Info
| ISIN | CNE1000012B3 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Distribution |
Highlights
| Market Cap | HK$67.61B |
|---|---|
| EPS (TTM) | HK$1.45 |
| PE Ratio | 10.47 |
| PEG Ratio | 1.34 |
| Total Revenue (TTM) | HK$197.86B |
| Gross Profit (TTM) | HK$22.13B |
| Year Range | HK$9.80 - HK$13.94 |
| Target Price | HK$15.38 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Shanghai Pharmaceuticals Holding Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Shanghai Pharmaceuticals Holding Co Ltd had a return of 4.94% year-to-date (YTD) and -16.66% in the last 12 months. Over the past 10 years, Shanghai Pharmaceuticals Holding Co Ltd had an annualized return of 0.50%, while the S&P 500 had an annualized return of 10.58%, indicating that Shanghai Pharmaceuticals Holding Co Ltd did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 4.94% | 13.20% |
| 1 month | 1.56% | -1.28% |
| 6 months | 2.78% | 10.32% |
| 1 year | -16.66% | 18.23% |
| 5 years (annualized) | -1.28% | 12.31% |
| 10 years (annualized) | 0.50% | 10.58% |
Monthly Returns
The table below presents the monthly returns of 2607.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -3.33% | 14.13% | -10.32% | -1.42% | 4.13% | 1.21% | 4.94% | ||||||
| 2023 | 6.32% | 0.29% | 5.78% | 8.74% | -2.01% | -0.51% | -4.58% | -8.64% | -5.27% | -6.87% | -0.53% | 0.88% | -7.72% |
| 2022 | 2.71% | -7.25% | 7.24% | -15.50% | 0.16% | 1.72% | -5.33% | -3.21% | -5.25% | -1.84% | 21.62% | 0.31% | -8.56% |
| 2021 | -1.47% | 5.96% | 7.31% | 15.86% | -0.79% | -3.31% | 1.26% | -6.76% | -2.07% | -5.69% | -0.28% | 3.94% | 12.54% |
| 2020 | -4.22% | -1.79% | -7.57% | 3.64% | -10.25% | 6.20% | 9.39% | 0.44% | -6.22% | -7.41% | 9.33% | 3.81% | -7.01% |
| 2019 | 4.90% | 5.63% | -3.06% | -3.98% | -5.72% | -0.78% | 1.50% | -2.12% | -4.05% | -0.14% | -0.99% | 7.98% | -1.81% |
| 2018 | -3.07% | -3.80% | 6.49% | 2.62% | 12.53% | -10.72% | -1.79% | -0.96% | -5.05% | -11.45% | 11.43% | -17.51% | -23.05% |
| 2017 | 11.70% | 0.70% | 1.75% | 1.23% | 9.47% | 3.10% | -9.32% | -6.96% | -0.93% | 5.61% | -2.63% | 7.80% | 21.16% |
| 2016 | -11.20% | -6.04% | 9.43% | 7.70% | 1.70% | 1.79% | 10.07% | 15.76% | -1.88% | -4.31% | -3.00% | -8.35% | 8.26% |
| 2015 | -4.00% | -3.57% | 27.16% | 17.48% | 6.20% | -14.57% | -15.00% | -11.98% | -0.00% | 11.14% | -5.23% | -1.41% | -2.54% |
| 2014 | 1.26% | 5.10% | -12.67% | -19.50% | 5.01% | 10.56% | -10.55% | 10.26% | 19.37% | 2.32% | -4.84% | -5.30% | -5.70% |
| 2013 | 4.86% | 7.60% | 2.28% | -6.44% | -5.26% | -1.94% | 10.87% | -8.68% | 1.22% | 7.25% | 13.64% | 4.52% | 30.94% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 2607.HK is 25, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Shanghai Pharmaceuticals Holding Co Ltd (2607.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Shanghai Pharmaceuticals Holding Co Ltd granted a 3.82% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.44 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.44 | HK$0.66 | HK$0.49 | HK$0.58 | HK$0.48 | HK$0.47 | HK$0.46 | HK$0.41 | HK$0.39 | HK$0.37 | HK$0.33 | HK$0.30 |
Dividend yield | 3.82% | 5.81% | 3.79% | 3.90% | 3.53% | 3.08% | 2.90% | 1.95% | 2.19% | 2.19% | 1.87% | 1.59% |
Monthly Dividends
The table displays the monthly dividend distributions for Shanghai Pharmaceuticals Holding Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.44 | HK$0.44 | |||||
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.66 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.66 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.49 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.49 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.58 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.58 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.48 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.48 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.47 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.47 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.46 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.46 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.41 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.41 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.39 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.39 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.37 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.37 |
| 2014 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.33 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.33 |
| 2013 | HK$0.30 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.30 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Shanghai Pharmaceuticals Holding Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Shanghai Pharmaceuticals Holding Co Ltd was 99.49%, occurring on Sep 23, 2008. Recovery took 658 trading sessions.
The current Shanghai Pharmaceuticals Holding Co Ltd drawdown is 46.17%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.49% | Nov 9, 2007 | 215 | Sep 23, 2008 | 658 | May 20, 2011 | 873 |
| -61.7% | May 27, 2011 | 250 | May 29, 2012 | 703 | Apr 2, 2015 | 953 |
| -56.01% | May 20, 2015 | 1195 | Mar 19, 2020 | — | — | — |
| -15.34% | Sep 25, 2007 | 1 | Sep 25, 2007 | 19 | Oct 25, 2007 | 20 |
| -9.59% | Apr 14, 2015 | 17 | May 7, 2015 | 5 | May 14, 2015 | 22 |
Volatility
Volatility Chart
The current Shanghai Pharmaceuticals Holding Co Ltd volatility is 7.13%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
P/E Ratio
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Shanghai Pharmaceuticals Holding Co Ltd.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |